tetano
Editor, Senior Moderator
Hematol Rep
. 2021 Mar 12;13(1):8874.
doi: 10.4081/hr.2021.8874. eCollection 2021 Mar 5.
Unusual presentation of COVID-19 in a child complicated by massive acute pulmonary embolism and lung infarction
Tahani Bin Ali[SUP] 1 [/SUP], Ghaleb Elyamany[SUP] 2 [/SUP], Maha Nojoom[SUP] 3 [/SUP], Mohamed Alfaki[SUP] 4 [/SUP], Hassan Alahmari[SUP] 4 [/SUP], Abdulwahab Alharthi[SUP] 1 [/SUP], Muwaffak Hijazi[SUP] 4 [/SUP], Atif Alsahari[SUP] 5 [/SUP], Fahad Alabbas[SUP] 1 [/SUP], Abdulnasir Al-Otaibi[SUP] 6 [/SUP]
Affiliations
Abstract
The Novel Coronavirus 2019 (SARSCoV- 2), which was first reported on in Wuhan, China, in late December 2019, causes a respiratory illness called COVID- 19 Disease. COVID-19 is most likely causing a hypercoagulable state, however the prevalence of acute venothromboembolism is still unknown. Limited data suggest pulmonary microvascular thrombosis may play a role in progressive respiratory failure. Here, we report a case of a child with an unusual presentation of COVID-19 presented initially by dry cough without fever and complicated by massive acute pulmonary embolism and lung infarction and treated successfully by hydroxychloroquine and azithromycin, in addition to anticoagulant therapy.
Keywords: COVID-19; acute venothromboembolism; antiphospholipid antibodies; lung infarction.
. 2021 Mar 12;13(1):8874.
doi: 10.4081/hr.2021.8874. eCollection 2021 Mar 5.
Unusual presentation of COVID-19 in a child complicated by massive acute pulmonary embolism and lung infarction
Tahani Bin Ali[SUP] 1 [/SUP], Ghaleb Elyamany[SUP] 2 [/SUP], Maha Nojoom[SUP] 3 [/SUP], Mohamed Alfaki[SUP] 4 [/SUP], Hassan Alahmari[SUP] 4 [/SUP], Abdulwahab Alharthi[SUP] 1 [/SUP], Muwaffak Hijazi[SUP] 4 [/SUP], Atif Alsahari[SUP] 5 [/SUP], Fahad Alabbas[SUP] 1 [/SUP], Abdulnasir Al-Otaibi[SUP] 6 [/SUP]
Affiliations
- PMID: 33747414
- PMCID: PMC7970399
- DOI: 10.4081/hr.2021.8874
Abstract
The Novel Coronavirus 2019 (SARSCoV- 2), which was first reported on in Wuhan, China, in late December 2019, causes a respiratory illness called COVID- 19 Disease. COVID-19 is most likely causing a hypercoagulable state, however the prevalence of acute venothromboembolism is still unknown. Limited data suggest pulmonary microvascular thrombosis may play a role in progressive respiratory failure. Here, we report a case of a child with an unusual presentation of COVID-19 presented initially by dry cough without fever and complicated by massive acute pulmonary embolism and lung infarction and treated successfully by hydroxychloroquine and azithromycin, in addition to anticoagulant therapy.
Keywords: COVID-19; acute venothromboembolism; antiphospholipid antibodies; lung infarction.